Related Experiment Video
Updated: May 8, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in
Sabrina Absalon1, Dawn M Kochanek, Venkatesan Raghavan
1Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Harvard Institutes of Medicine, Boston, Massachusetts 02115.
Abstract:
MicroRNA (miRNA) functions in the pathogenesis of major neurodegenerative diseases such as Alzheimer's disease (AD) are only beginning to emerge. We have observed significantly elevated levels of a specific miRNA, miR-26b, in the defined pathological areas of human postmortem brains, starting from early stages of AD (Braak III). Ectopic overexpression of miR-26b in rat primary postmitotic neurons led to the DNA replication and aberrant cell cycle entry (CCE) and, in parallel, increased tau-phosphorylation, which culminated in the apoptotic cell death of neurons. Similar tau hyperphosphorylation and CCE are typical features of neurons in pre-AD brains. Sequence-specific inhibition of miR-26b in culture is neuroprotective against oxidative stress. Retinoblastoma protein (Rb1), a major tumor suppressor, appears as the key direct miR-26b target, which mediates the observed neuronal phenotypes. The downstream signaling involves upregulation of Rb1/E2F cell cycle and pro-apoptotic transcriptional targets, including cyclin E1, and corresponding downregulation of cell cycle inhibitor p27/Kip1. It further leads to nuclear export and activation of Cdk5, a major kinase implicated in tau phosphorylation, regulation of cell cycle, and death in postmitotic neurons. Therefore, upregulation of miR-26b in neurons causes pleiotropic phenotypes that are also observed in AD. Elevated levels of miR-26b may thus contribute to the AD neuronal pathology.
Insights
Elevated microRNA-26b (miR-26b) levels in Alzheimer
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNA (miRNA) roles in neurodegenerative diseases like Alzheimer's disease (AD) are emerging.
- Specific miRNAs may drive key pathological features observed in AD brains.
Purpose of the Study:
- To investigate the role of miR-26b in Alzheimer's disease pathogenesis.
- To identify the molecular mechanisms by which miR-26b influences neuronal function and survival.
Main Methods:
- Analysis of miR-26b levels in human postmortem Alzheimer's disease brains.
- Overexpression and inhibition of miR-26b in primary rat neurons.
- Assessment of cell cycle regulation, tau phosphorylation, and apoptosis.
- Identification of direct miR-26b targets using molecular assays.
Main Results:
- Significantly elevated miR-26b levels were found in early-stage AD brains.
- miR-26b overexpression induced aberrant cell cycle entry, tau hyperphosphorylation, and neuronal apoptosis.
- Inhibition of miR-26b demonstrated neuroprotective effects against oxidative stress.
- Retinoblastoma protein (Rb1) was identified as a direct miR-26b target, mediating downstream effects.
- Upregulation of miR-26b led to altered expression of cell cycle regulators (e.g., cyclin E1, p27/Kip1) and activation of Cdk5.
Conclusions:
- Upregulated miR-26b in neurons recapitulates key pathological phenotypes of Alzheimer's disease.
- miR-26b contributes to neurodegeneration by disrupting cell cycle control and promoting apoptosis.
- miR-26b represents a potential therapeutic target for Alzheimer's disease intervention.
Related Concept Videos
Microtubule Associated Proteins (MAPs)
Microtubule Instability
Abnormal Proliferation
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

